[18F]Fluoride PET provides distinct information on disease activity in ankylosing spondylitis as compared to MRI and conventional radiography

[1]  P. Carron,et al.  Use of Imaging in Axial Spondyloarthritis for Diagnosis and Assessment of Disease Remission in the Year 2022 , 2022, Current Rheumatology Reports.

[2]  C. Lau,et al.  MRI inflammation of facet and costovertebral joints is associated with restricted spinal mobility and worsened functional status. , 2020, Rheumatology.

[3]  D. Loeuille,et al.  Performance of 18F-sodium fluoride positron emission tomography with computed tomography to assess inflammatory and structural sacroiliitis on magnetic resonance imaging and computed tomography, respectively, in axial spondyloarthritis , 2019, Arthritis Research & Therapy.

[4]  H. Quick,et al.  Dual‐phase hybrid 18F‐Fluoride Positron emission tomography/MRI in ankylosing spondylitis: Investigating the link between MRI bone changes, regional hyperaemia and increased osteoblastic activity , 2018, Journal of medical imaging and radiation oncology.

[5]  A. Lammertsma,et al.  Bone formation in ankylosing spondylitis during anti-tumour necrosis factor therapy imaged by 18F-fluoride positron emission tomography , 2018, Rheumatology.

[6]  Kyoungjune Pak,et al.  Baseline increased 18F-fluoride uptake lesions at vertebral corners on positron emission tomography predict new syndesmophyte development in ankylosing spondylitis: a 2-year longitudinal study , 2017, Rheumatology International.

[7]  Matthias Schneider,et al.  Hybrid 18F-labeled Fluoride Positron Emission Tomography/Magnetic Resonance (MR) Imaging of the Sacroiliac Joints and the Spine in Patients with Axial Spondyloarthritis: A Pilot Study Exploring the Link of MR Bone Pathologies and Increased Osteoblastic Activity , 2015, The Journal of Rheumatology.

[8]  R. Landewé,et al.  Descriptions of spinal MRI lesions and definition of a positive MRI of the spine in axial spondyloarthritis: a consensual approach by the ASAS/OMERACT MRI study group , 2012, Annals of the rheumatic diseases.

[9]  R. Boellaard,et al.  Bone formation rather than inflammation reflects Ankylosing Spondylitis activity on PET-CT: a pilot study , 2012, Arthritis Research & Therapy.

[10]  M. Østergaard,et al.  Imaging in ankylosing spondylitis , 2012, Therapeutic advances in musculoskeletal disease.

[11]  D. M. van der Heijde,et al.  Health and imaging outcomes in axial spondyloarthritis , 2016 .

[12]  W. Maksymowych,et al.  Focal fat lesions at vertebral corners on magnetic resonance imaging predict the development of new syndesmophytes in ankylosing spondylitis. , 2011, Arthritis and rheumatism.

[13]  W. Maksymowych,et al.  Magnetic resonance imaging assessment of spinal inflammation in ankylosing spondylitis: standard clinical protocols may omit inflammatory lesions in thoracic vertebrae. , 2009, Arthritis and rheumatism.

[14]  J. Braun,et al.  The relationship between inflammation and new bone formation in patients with ankylosing spondylitis , 2008, Arthritis research & therapy.

[15]  M. Dougados,et al.  Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis , 2008, Annals of the rheumatic diseases.

[16]  J. Sieper,et al.  The challenge of diagnosis and classification in early ankylosing spondylitis: do we need new criteria? , 2005, Arthritis and rheumatism.

[17]  M. A. van 't Hof,et al.  Assessment of outcome in ankylosing spondylitis: an extended radiographic scoring system , 2004, Annals of the rheumatic diseases.

[18]  A. Cats,et al.  Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. , 1984, Arthritis and rheumatism.

[19]  J. Forestier,et al.  Radiological Study of Sacro-Iliac Joints in Ankylosing Spondylitis with Reference to the Evolution of the Disease * , 1957, Annals of the rheumatic diseases.